共 50 条
- [1] SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series Internal and Emergency Medicine, 2022, 17 : 1243 - 1245
- [2] “SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series” comment Internal and Emergency Medicine, 2022, 17 : 1553 - 1554
- [7] SGLT2i Prescribers Among CKD Patients: Trends in Real-World Data (RWD) JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 573 - 573
- [10] SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices ESC HEART FAILURE, 2025,